Otsuka Medical Devices

Otsuka Medical Devices Co., Ltd. is a core subsidiary of Otsuka Holdings focused on the global development of innovative medical device solutions. The company specializes in endovascular treatments, particularly for hypertension and peripheral arterial disease, through its key subsidiaries ReCor Medical and Veryan Medical. Its flagship product, the Paradise Ultrasound Renal Denervation System, is a first-in-class device approved by the FDA for the treatment of hypertension. Additionally, the company manages Jimro Co., Ltd., which provides apheresis technologies for inflammatory bowel disease. Otsuka Medical Devices leverages a combination of pharmaceutical heritage and engineering expertise to address chronic conditions that are difficult to manage with medication alone.